ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Expected to Post Quarterly Sales of $70.20 Million

Equities research analysts expect that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) will report $70.20 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for ANI Pharmaceuticals’ earnings, with the highest sales estimate coming in at $71.30 million and the lowest estimate coming in at $69.10 […]

Related Keywords

Tennessee ,United States ,Canada ,America ,Nikhil Lalwani ,Raymond James ,Patrickd Walsh ,Life Insurance Co ,Zacks Investment Research ,Nasdaq ,Pharmaceuticals Company Profile Get Rating ,Mutual Of America Capital Management ,Financial Services Group Inc ,Cantor Fitzgerald ,Tennessee Treasury Department ,Pharmaceuticals Inc ,Get Rating ,Zacks Investment ,Investment Research ,Director Patrick ,America Capital Management ,Services Group ,Company Profile ,Ani Pharmaceuticals ,Nasdaq Anip ,Manip ,Medical ,Ratings ,Consensus ,